PMDA
- Application: Xalkori Initial Approval
- Local brand name: Xalkori Initial Approval
- Status: approved
🇯🇵 CRIZOTINIB in Japan
CRIZOTINIB (CRIZOTINIB) regulatory status in Japan.
Marketing authorisations
PMDA
- Application: Xalkori Partial Change Approval
- Local brand name: Xalkori Partial Change Approval
- Status: approved
CRIZOTINIB in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is CRIZOTINIB approved in Japan?
Yes. PMDA has authorised it; PMDA has authorised it.
Who is the marketing authorisation holder for CRIZOTINIB in Japan?
Marketing authorisation holder not available in our data.